3,869
Views
79
CrossRef citations to date
0
Altmetric
Research Paper

Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer

, , &
Pages 1213-1225 | Received 21 May 2013, Accepted 03 Sep 2013, Published online: 12 Sep 2013

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
  • Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890 - 907; http://dx.doi.org/10.1016/S0140-6736(07)61416-0; PMID: 17826171
  • Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006; 24:1 - 10; http://dx.doi.org/10.1016/j.vaccine.2006.05.115; PMID: 16122853
  • Whiteside MA, Siegel EM, Unger ER. Human papillomavirus and molecular considerations for cancer risk. Cancer 2008; 113:Suppl 2981 - 94; http://dx.doi.org/10.1002/cncr.23750; PMID: 18980282
  • Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
  • Schmitz M, Driesch C, Jansen L, Runnebaum IB, Dürst M. Non-random integration of the HPV genome in cervical cancer. PLoS One 2012; 7:e39632; http://dx.doi.org/10.1371/journal.pone.0039632; PMID: 22761851
  • Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von Knebel Doeberitz M. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 2003; 22:3977 - 84; http://dx.doi.org/10.1038/sj.onc.1206629; PMID: 12813471
  • Li W, Wang W, Si M, Han LF, Gao QL, Luo AY, Li Y, Lu Y, Wang S, Ma D. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol 2008; 134:1355 - 61; http://dx.doi.org/10.1007/s00432-008-0413-3; PMID: 18478264
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
  • Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43:768 - 75; http://dx.doi.org/10.1038/ng.865; PMID: 21706001
  • Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178 - 86; http://dx.doi.org/10.1038/ng.298; PMID: 19151715
  • Yanatatsaneejit P, Mutirangura A, Kitkumthorn N. Human papillomavirus’s physical state and cyclin A1 promoter methylation in cervical cancer. Int J Gynecol Cancer 2011; 21:902 - 6; http://dx.doi.org/10.1097/IGC.0b013e3182158683; PMID: 21412159
  • Mazumder Indra D, Singh RK, Mitra S, Dutta S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S, Panda CK. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Gynecol Oncol 2011; 123:597 - 604; http://dx.doi.org/10.1016/j.ygyno.2011.08.004; PMID: 21911249
  • Szalmás A, Kónya J. Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol 2009; 19:144 - 52; http://dx.doi.org/10.1016/j.semcancer.2009.02.011; PMID: 19429477
  • Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2009; 112:293 - 9; http://dx.doi.org/10.1016/j.ygyno.2008.10.012; PMID: 19054549
  • Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM, et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 2007; 67:4605 - 19; http://dx.doi.org/10.1158/0008-5472.CAN-06-3619; PMID: 17510386
  • Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 2008; 47:755 - 65; http://dx.doi.org/10.1002/gcc.20577; PMID: 18506748
  • Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER, Cho KR. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 2007; 67:10163 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-07-2056; PMID: 17974957
  • Lendvai A, Johannes F, Grimm C, Eijsink JJH, Wardenaar R, Volders HH, Klip HG, Hollema H, Jansen RC, Schuuring E, et al. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics 2012; 7:1268 - 78; http://dx.doi.org/10.4161/epi.22301; PMID: 23018867
  • Kim YI, Giuliano A, Hatch KD, Schneider A, Nour MA, Dallal GE, Selhub J, Mason JB. Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 1994; 74:893 - 9; http://dx.doi.org/10.1002/1097-0142(19940801)74:3<893::AID-CNCR2820740316>3.0.CO;2-B; PMID: 8039116
  • Shen XP, He Z, Li HD, Yao C, Zhang Y, He L, Li S, Huang J, Guo Z. Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomes. PLoS One 2012; 7:e44822; http://dx.doi.org/10.1371/journal.pone.0044822; PMID: 22970311
  • Lindqvist BM, Farkas SA, Wingren S, Nilsson TK. DNA methylation pattern of the SLC25A43 gene in breast cancer. Epigenetics 2012; 7:300 - 6; http://dx.doi.org/10.4161/epi.7.3.19064; PMID: 22430806
  • Feber A, Wilson GA, Zhang L, Presneau N, Idowu B, Down TA, Rakyan VK, Noon LA, Lloyd AC, Stupka E, et al. Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Res 2011; 21:515 - 24; http://dx.doi.org/10.1101/gr.109678.110; PMID: 21324880
  • Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692 - 702; http://dx.doi.org/10.4161/epi.6.6.16196; PMID: 21593595
  • Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288 - 95; http://dx.doi.org/10.1016/j.ygeno.2011.07.007; PMID: 21839163
  • Kalari S, Pfeifer GP. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 2010; 70:277 - 308; http://dx.doi.org/10.1016/B978-0-12-380866-0.60010-1; PMID: 20920752
  • Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, Yo YT, Chao TK, Huang HC, Lin CY, et al. Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. PLoS One 2012; 7:e41060; http://dx.doi.org/10.1371/journal.pone.0041060; PMID: 22815913
  • Misawa K, Ueda Y, Kanazawa T, Misawa Y, Jang I, Brenner JC, Ogawa T, Takebayashi S, Grenman RA, Herman JG, et al. Epigenetic inactivation of galanin receptor 1 in head and neck cancer. Clin Cancer Res 2008; 14:7604 - 13; http://dx.doi.org/10.1158/1078-0432.CCR-07-4673; PMID: 19047085
  • Ge L, Cornforth AN, Hoa NT, Delgado C, Chiou SK, Zhou YH, Jadus MR. Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia. PLoS One 2012; 7:e42661; http://dx.doi.org/10.1371/journal.pone.0042661; PMID: 22957023
  • Pedersen KS, Bamlet WR, Oberg AL, de Andrade M, Matsumoto ME, Tang H, Thibodeau SN, Petersen GM, Wang L. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One 2011; 6:e18223; http://dx.doi.org/10.1371/journal.pone.0018223; PMID: 21455317
  • Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Shen L, Kantarjian HM, Estecio MR, Jelinek J, Godley LA, et al. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics 2012; 7:201 - 7; http://dx.doi.org/10.4161/epi.7.2.19015; PMID: 22395470
  • Piersma SJ, Welters MJ, van der Hulst JM, Kloth JN, Kwappenberg KM, Trimbos BJ, Melief CJ, Hellebrekers BW, Fleuren GJ, Kenter GG, et al. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element. Int J Cancer 2008; 122:486 - 94; http://dx.doi.org/10.1002/ijc.23162; PMID: 17955486
  • Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24 Suppl 3:S3/42-51.
  • Feller L, Wood NH, Khammissa RA, Chikte UM, Meyerov R, Lemmer J. HPV modulation of host immune responses. SADJ 2010; 65:266 - 8; PMID: 20879650
  • Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest 2007; 117:1137 - 46; http://dx.doi.org/10.1172/JCI31405; PMID: 17476343
  • Lu HT, Ouyang WM, Huang CS. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4:221 - 33; http://dx.doi.org/10.1158/1541-7786.MCR-05-0261; PMID: 16603636
  • Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143:550 - 63; http://dx.doi.org/10.1053/j.gastro.2012.07.009; PMID: 22796521
  • Doerfler W. Adenoviruses. In: Baron S, ed. Medical Microbiology. Galveston (TX): University of Texas Medical Branch at Galveston The University of Texas Medical Branch at Galveston, 1996.
  • Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, Ryan F, Smedby KE, Juliusson G, Sundström C, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013; 27:150 - 8; http://dx.doi.org/10.1038/leu.2012.245; PMID: 22922567
  • Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O, Karimi M, Bengtzén S, Nahi H, Uggla B, et al. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood 2011; 118:5573 - 82; http://dx.doi.org/10.1182/blood-2011-01-332353; PMID: 21960591
  • Ovanin-Rakic A, Pajtler M, Stanković T, Audy-Jurković S, Ljubojević N, Grubišić G, et al. The classification of cytologic findings of cervix uteri “Zagreb 2002”: The Modification of the “Zagreb 1990” and “NCI Bethesda System 2001” Classifications. Gynaecologia Et Perinatologia 2003; 12:148 - 53
  • Milutin-Gasperov N, Sabol I, Halec G, Matovina M, Grce M. Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women. Coll Antropol 2007; 31:Suppl 2 89 - 96; PMID: 17598510
  • J S. EF F, T M. Molecular cloning - A laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1982.
  • Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357 - 61; PMID: 10618116
  • Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991; 82:524 - 31; http://dx.doi.org/10.1111/j.1349-7006.1991.tb01882.x; PMID: 1648051
  • van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40:779 - 87; http://dx.doi.org/10.1128/JCM.40.3.779-787.2002; PMID: 11880393
  • Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85:1159 - 64; http://dx.doi.org/10.1093/jnci/85.14.1159; PMID: 8320745
  • Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44 - 57; http://dx.doi.org/10.1038/nprot.2008.211; PMID: 19131956
  • Farkas SA, Böttiger AK, Isaksson HS, Finnell RH, Ren A, Nilsson TK. Epigenetic alterations in folate transport genes in placental tissue from fetuses with neural tube defects and in leukocytes from subjects with hyperhomocysteinemia. Epigenetics 2013; 8:303 - 16; http://dx.doi.org/10.4161/epi.23988; PMID: 23417011
  • Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, Ambrosone CB, Johnson CS, Smiraglia DJ, Liu S. IMA: an R package for high-throughput analysis of Illumina’s 450K Infinium methylation data. Bioinformatics 2012; 28:729 - 30; http://dx.doi.org/10.1093/bioinformatics/bts013; PMID: 22253290
  • Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:e3; http://dx.doi.org/10.2202/1544-6115.1027; PMID: 16646809
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and poerful approach to multiple testing. J R Stat Soc, B 1995; 57:289 - 300
  • Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65 - 70
  • Jeffries MA, Dozmorov M, Tang Y, Merrill JT, Wren JD, Sawalha AH. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011; 6:593 - 601; http://dx.doi.org/10.4161/epi.6.5.15374; PMID: 21436623
  • Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 2010; 11:701; http://dx.doi.org/10.1186/1471-2164-11-701; PMID: 21156036
  • Zawada AM, Rogacev KS, Hummel B, Grün OS, Friedrich A, Rotter B, Winter P, Geisel J, Fliser D, Heine GH. SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes. Circ Cardiovasc Genet 2012; 5:611 - 20; http://dx.doi.org/10.1161/CIRCGENETICS.112.963207; PMID: 23074332
  • Lübbert M, Tobler A, Daskalakis M. Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development. Leukemia 1999; 13:1420 - 7; http://dx.doi.org/10.1038/sj.leu.2401486; PMID: 10482994
  • Zhang Q, Wang HY, Liu X, Wasik MA. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nat Med 2007; 13:1341 - 8; http://dx.doi.org/10.1038/nm1659; PMID: 17922009
  • Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. England, 2011:492-7.
  • Jung S, Yi L, Jeong D, Kim J, An S, Oh TJ, Kim CH, Kim CJ, Yang Y, Kim KI, et al. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer. Oncol Rep 2011; 25:245 - 52; PMID: 21109983
  • Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y, Hino R, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. United States, 2011:7187-97.
  • Cogdell D, Chung W, Liu Y, McDonald JM, Aldape K, Issa JP, et al. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. Chin J Cancer. China, 2011:247-53.
  • Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD, Pfeifer GP. DNA methylation biomarkers for lung cancer. Tumour Biol 2012; 33:287 - 96; http://dx.doi.org/10.1007/s13277-011-0282-2; PMID: 22143938
  • Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ, et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol 2011; 18:2338 - 47; http://dx.doi.org/10.1245/s10434-011-1573-y; PMID: 21298349
  • Tessema M, Yu YY, Stidley CA, Machida EO, Schuebel KE, Baylin SB, Belinsky SA. Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers. Carcinogenesis 2009; 30:1132 - 8; http://dx.doi.org/10.1093/carcin/bgp114; PMID: 19435948
  • Ramos EA, Camargo AA, Braun K, Slowik R, Cavalli IJ, Ribeiro EM, Pedrosa FdeO, de Souza EM, Costa FF, Klassen G. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer. BMC Cancer 2010; 10:23; http://dx.doi.org/10.1186/1471-2407-10-23; PMID: 20109227
  • Karouzakis E, Rengel Y, Jungel A, Kolling C, Gay RE, Michel BA, et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun. England, 2011:643-52.
  • Yoshino M, Suzuki M, Tian L, Moriya Y, Hoshino H, Okamoto T, Yoshida S, Shibuya K, Yoshino I. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers. Int J Oncol 2009; 35:1201 - 9; PMID: 19787276
  • Zhou W, Jiang Z, Song X, Liu Y, Wen P, Guo Y, Xu F, Kong L, Zhang P, Han A, et al. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma. J Neurosci Res 2008; 86:3002 - 10; http://dx.doi.org/10.1002/jnr.21746; PMID: 18512766
  • Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006; 25:4986 - 97; http://dx.doi.org/10.1038/sj.onc.1209505; PMID: 16568088
  • Sato N, Matsubayashi H, Fukushima N, Goggins M. The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. Cancer Biol Ther 2005; 4:70 - 6; http://dx.doi.org/10.4161/cbt.4.1.1378; PMID: 15662133
  • Shen RZ, Pan S, Qi SJ, Lin XL, Cheng SD. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem Biophys Res Commun 2010; 394:1047 - 52; http://dx.doi.org/10.1016/j.bbrc.2010.03.121; PMID: 20331975
  • Reinert T, Modin C, Castano FM, Lamy P, Wojdacz TK, Hansen LL, Wiuf C, Borre M, Dyrskjøt L, Orntoft TF. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin Cancer Res 2011; 17:5582 - 92; http://dx.doi.org/10.1158/1078-0432.CCR-10-2659; PMID: 21788354
  • Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, Sugimoto T, Imoto I, Inazawa J. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 2007; 26:7401 - 13; http://dx.doi.org/10.1038/sj.onc.1210550; PMID: 17533365
  • Isidoro-García M, Sanz C, García-Solaesa V, Pascual M, Pescador DB, Lorente F, Dávila I. PTGDR gene in asthma: a functional, genetic, and epigenetic study. Allergy 2011; 66:1553 - 62; http://dx.doi.org/10.1111/j.1398-9995.2011.02685.x; PMID: 21883277
  • Yi JM, Dhir M, Guzzetta AA, Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM, Ahuja N. DNA methylation biomarker candidates for early detection of colon cancer. Tumour Biol 2012; 33:363 - 72; http://dx.doi.org/10.1007/s13277-011-0302-2; PMID: 22238052
  • Koch CM, Wagner W. Epigenetic-aging-signature to determine age in different tissues. Aging (Albany NY) 2011; 3:1018 - 27; PMID: 22067257
  • Tao R, Li J, Xin J, Wu J, Guo J, Zhang L, Jiang L, Zhang W, Yang Z, Li L. Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. PLoS One 2011; 6:e19862; http://dx.doi.org/10.1371/journal.pone.0019862; PMID: 21625442
  • Arai E, Chiku S, Mori T, Gotoh M, Nakagawa T, Fujimoto H, Kanai Y. Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Carcinogenesis 2012; 33:1487 - 93; http://dx.doi.org/10.1093/carcin/bgs177; PMID: 22610075
  • Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 2009; 115:3412 - 26; http://dx.doi.org/10.1002/cncr.24394; PMID: 19472401
  • Oster B, Thorsen K, Lamy P, Wojdacz TK, Hansen LL, Birkenkamp-Demtröder K, Sørensen KD, Laurberg S, Orntoft TF, Andersen CL. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer 2011; 129:2855 - 66; http://dx.doi.org/10.1002/ijc.25951; PMID: 21400501
  • Morris MR, Ricketts CJ, Gentle D, McRonald F, Carli N, Khalili H, Brown M, Kishida T, Yao M, Banks RE, et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 2011; 30:1390 - 401; http://dx.doi.org/10.1038/onc.2010.525; PMID: 21132003

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.